Event

Big Problems Need Big Solutions - Fixing the Health Care System Using Big Data

3:45 PM - 5:00 PM on Monday, Apr 22, 2013


Description: Companies like Google have changed the way we live and interact with the world. The biopharma industry started realizing the potential of big data as genomics companies quietly began using it...
Event

Biosimilars: Strategic Considerations for Regulatory Approval and Patents under the BPCIA

3:45 PM - 5:00 PM on Tuesday, Apr 23, 2013


Description: Congress passed the Biologics Price Competition and Innovation Act (BPCIA) two years ago in an effort to make affordable biologics available to patients. While generic biologics have been approved and marketed...
Event

Challenges and Opportunities for Small Companies in AgBiotech: Collaborating and Competing with the Majors

3:45 PM - 5:00 PM on Tuesday, Apr 23, 2013


Description: In an industry dominated by a few big, multinational corporations, it is easy to overlook the contributions made by small companies. Likewise, it can be difficult for small companies to develop...
Event

Clinical Trials Modernization: Confronting Challenges to Study Start-Up - Avoid Delays, Improve Efficiency, Mitigate Risk

9:00 AM - 10:15 AM on Wednesday, Apr 24, 2013


Description: Conducting a modern clinical trial requires coordination of a large and diverse group of stakeholders – including patients, clinical investigators, physicians, regulators, and the research sponsors. Studies have suggested that barriers...
Event

Economic Impact of Implementing a National Serialization and Traceability System

2:30 PM - 3:30 PM on Tuesday, Apr 23, 2013


Description: Lawmakers are considering a federal standard to improve the security of drug distribution and reduce the risk of counterfeit and diverted medicines entering the legitimate pharmaceutical supply chain. However, they are...
Event

Finding Common Ground: Can Payers and Biopharma Agree on Therapeutic Value?

2:30 PM - 3:30 PM on Wednesday, Apr 24, 2013


Description: Payers and employers often see corporate R&D as a mechanism for price increases and smart life cycle management. Pharmas just as often see payers and corporate health care buyers as obstacles...
Event

How to Adapt: International Consortium Lays Groundwork for Adaptive Licensing

2:30 PM - 3:30 PM on Tuesday, Apr 23, 2013


Description: Adaptive approaches to licensing represent an important evolutionary path for drug development, regulation, and learning that can benefit all parties – patients, payers, providers, regulators and drug developers. They may also...
Event

Innovation & Solutions for Agricultural Biotechnology in Taiwan

11:00 AM - 11:45 AM on Wednesday, Apr 24, 2013


Description: The Taiwanese government is working to transform and upgrade its traditional agriculture industries to spur biotech innovation in human pharmaceuticals, animal vaccines and food production. Specific regulatory initiatives focus on: (1)...
Event

Lithuanian Biotech - Innovations in Health

9:00 AM - 9:45 AM on Monday, Apr 22, 2013


Description: The Lithuanian government is focused on life science innovation as a cornerstone for promoting competitiveness and growth of the country. Key areas include: biotechnology, pharmaceuticals, medical devices, and related fields. The...
Event

Next-Generation Biomanufacturing Facilities: Beyond Compliance to Process Excellence

3:45 PM - 5:00 PM on Tuesday, Apr 23, 2013


Description: Business dynamics and regulatory forces are driving significant changes in biopharmaceutical manufacturing. Innovation in the way facilities are designed and fabricated is focused on the need for speed in both process...
Event

Partnering for Effective Drug Development: 90% Joy, 100% Misery or 110% Synergy

3:45 PM - 5:00 PM on Tuesday, Apr 23, 2013


Description: Finding and applying synergies among industry, academia, patients and non-profit foundations can significantly minimize the risk of failure and increase the probability of success in drug discovery and development. In...
Event

Role of Public-Private Partnerships in Addressing Non-Communicable Diseases in Low- and Middle-Income Countries

9:00 AM - 10:15 AM on Wednesday, Apr 24, 2013


Description: As global rates of infectious disease continue to decline, rates of cancer and other non-communicable diseases (NCDs) are projected to continue rising in low- and middle-income countries (LMCs). Most LMCs are...
Event

The Unitary Patent: How Will it Affect the Biotech Sector and Your Business?

3:45 PM - 5:00 PM on Monday, Apr 22, 2013


Description: The EU Council decision to establish a unitary patent system for 25 countries paves the way for a Pan-European patent system – something that has been eagerly awaited by industry. Unitary...